• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force

tetano

Editor, Senior Moderator
Allergy. 2017 Nov 6. doi: 10.1111/all.13333. [Epub ahead of print]
[h=1]Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force.[/h] Schwarze J[SUP]1[/SUP], Openshaw P[SUP]2[/SUP], Jha A[SUP]2[/SUP], Del Giacco SR[SUP]3[/SUP], Firinu D[SUP]3[/SUP], Tsilochristou O[SUP]4[/SUP], Roberts G[SUP]5[/SUP], Selby A[SUP]5[/SUP], Akdis C[SUP]6[/SUP], Agache I[SUP]7[/SUP], Custovic A[SUP]8[/SUP], Heffler E[SUP]9[/SUP], Pinna G[SUP]10[/SUP], Khaitov M[SUP]11[/SUP], Nikonova A[SUP]11[/SUP], Papadopoulos N[SUP]12[/SUP], Akhlaq A[SUP]13[/SUP], Nurmatov U[SUP]14[/SUP], Renz H[SUP]15[/SUP], Sheikh A[SUP]16[/SUP], Skevaki C[SUP]15[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] To address uncertainties in the prevention and management of influenza in people with asthma, we performed a scoping review of the published literature on influenza burden; current vaccine recommendations; vaccination coverage; immunogenicity, efficacy, effectiveness and safety of influenza vaccines; and the benefits of antiviral drugs in people with asthma. We found significant variation in the reported rates of influenza detection in individuals with acute asthma exacerbations making it unclear to what degree influenza causes exacerbations of underlying asthma. The strongest evidence of an association was seen in studies of children. Countries in the European Union currently recommend influenza vaccination of adults with asthma; however, coverage varied between regions. Coverage was lower among children with asthma. Limited data suggest that good seroprotection and seroconversion can be achieved in both children and adults with asthma and that vaccination confers a degree of protection against influenza illness and asthma related morbidity to children with asthma. There were insufficient data to determine efficacy in adults. Overall, influenza vaccines appeared to be safe for people with asthma. We identify knowledge gaps and make recommendations on future research needs in relation to influenza in patients with asthma. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Viral infection; antivirals; heath care utilization; respiratory; vaccination

PMID: 29105786 DOI: 10.1111/all.13333
 
Back
Top Bottom